Skip to content

Influence of perioperative administration of low molecule weight heparin combined with postoperative patient controlled analgesia to the mortality within 24h after underwent amputation in patients with peripheral artery disease

Influence of perioperative administration of low molecule weight heparin combined with postoperative patient controlled analgesia to the mortality within 24h after underwent amputation in patients with peripheral artery disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONC-14004152
Enrollment
Unknown
Registered
2014-01-04
Start date
2014-03-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

peripheral artery disease

Interventions

case series:low molecule weight heparin combined with postoperative patients controlled analgesia

Sponsors

First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients with 30~80 years of ages who were suggested to undergoing amputation for the cause of peripheral artery disease, and those who would be willing to provide written informed consent would be included in this study.

Exclusion criteria

Exclusion criteria: congenital or hereditary coagulation dysfunction, abnormal platelet count or platelet dysfunction, preoperative cerebral hemorrhage or neurosurgery in preceding 3 months, traumatic-caused limb ischemia, active peptic ulcer.

Design outcomes

Primary

MeasureTime frame
All-cause mortality within 24h after surgery;

Secondary

MeasureTime frame
Incidence of acute coronary syndrome;Incidence of arrhythmia;Incidence of cerebral embolism or thrombosis;Incidence of embolism or thrombosis in peripheral;

Countries

China

Contacts

Public ContactMin Su

Department of Anesthesiology, the First Affiliated Hospital of Chongqing Medical University

ms89011068@163.com+86 13508302749

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026